At the time of writing, Pulse Biosciences Inc [PLSE] stock is trading at $18.43, down -0.65%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PLSE shares have gain 5.86% over the last week, with a monthly amount drifted -6.68%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pulse Biosciences Inc [NASDAQ: PLSE] stock has seen the most recent analyst activity on July 27, 2021, when Stephens initiated its Overweight rating and assigned the stock a price target of $28. Previously, Maxim Group started tracking the stock with Buy rating on March 11, 2021, and set its price target to $40. On January 26, 2021, H.C. Wainwright reiterated its Buy rating and revised its price target to $40 on the stock. H.C. Wainwright upgraded its rating to a Buy and increased its price target to $16 on May 12, 2020. H.C. Wainwright downgraded its rating to a Neutral and reduced its price target to $6 on February 14, 2020. H.C. Wainwright started tracking with a Buy rating for this stock on February 25, 2019, and assigned it a price target of $27.
For the past year, the stock price of Pulse Biosciences Inc fluctuated between $6.59 and $22.69. Pulse Biosciences Inc [NASDAQ: PLSE] shares were valued at $18.43 at the most recent close of the market.
Analyzing the PLSE fundamentals
Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at -27.89%, Pretax Profit Margin comes in at -26.51%, and Net Profit Margin reading is -26.51%. To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -0.99 and Total Capital is -0.56. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.13 points at the first support level, and at 17.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.60, and for the 2nd resistance point, it is at 18.76.
Ratios To Look Out For
It is important to note that Pulse Biosciences Inc [NASDAQ:PLSE] has a current ratio of 11.93. As well, the Quick Ratio is 11.93, while the Cash Ratio is 11.72.
Transactions by insiders
Recent insider trading involved Barrett Burke Thomas, Former President and CEO, that happened on Dec 11 ’24 when 50000.0 shares were sold. Director, DUGGAN ROBERT W completed a deal on Dec 13 ’24 to buy 55256.0 shares. Meanwhile, Director DUGGAN ROBERT W bought 45404.0 shares on Dec 12 ’24.
